Arkolith/Insider Trading/LXRX/Form 4

DeFrancesco Lisa

SVP, IR and Corp CommLEXICON PHARMACEUTICALS, INC. (LXRX) · full profile →Form 4 · filed Mar 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 28, 2026Tax withholding(F)75K$1.47$110K94K
Feb 28, 2026Option exercise(M)128K——168K
Feb 28, 2026Option exercise(M)25K——40K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 28, 2026Option exercise(M)25K——25K
Feb 28, 2026Option exercise(M)128K——256K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062822-26-000037) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML